Watch BSX. Know when insiders buy.
One email the day a filing lands. Free.
Work order
31
FLAG · insiders 60, shorts 2
Insiders, 90 days
+$100K
net buying · 1 buy, 0 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
5 / 15
tracked funds hold it
Calls on record
0
nobody we score has called it yet
MKT CAP $69.3BP/E 19.4DIV YIELD —FCF YIELD 5.23%REV TTM $21B +13.5%NET INCOME $3.7B +46.9%NET DEBT $4.3B52W 42.63 – 108.14SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $5.4B | +7.5% | 70.7% | $1.2B | $905M | +13.8% | 0.61 | $1.5B | $195M | $1.3B | Aug 3 |
| Q1 2026 · Mar 31 | $5.2B | +11.6% | 69.5% | $1.1B | $1.3B | +99.3% | 0.90 | $348M | $177M | $171M | May 1 |
| Q4 2025 · Dec 31derived | $5.3B | +15.9% | 69.6% | $825M | $670M | +19.2% | 0.45 | $1.4B | $351M | $1B | Feb 17 |
| Q3 2025 · Sep 30 | $5.1B | +20.3% | 69.9% | $1B | $755M | +61.3% | 0.51 | $1.3B | $181M | $1.2B | Nov 3 |
| Q2 2025 · Jun 30 | $5.1B | +22.8% | 67.7% | $819M | $795M | +146.9% | 0.53 | $1.3B | $157M | $1.1B | Aug 3 |
| Q1 2025 · Mar 31 | $4.7B | +20.9% | 68.8% | $921M | $672M | +36.3% | 0.45 | $541M | $187M | $354M | May 1 |
| Q4 2024 · Dec 31derived | $4.6B | +22.4% | 67.9% | $675M | $562M | +11.5% | 0.38 | $1.5B | $277M | $1.2B | Feb 17 |
| Q3 2024 · Sep 30 | $4.2B | +19.3% | 68.8% | $733M | $468M | −7.1% | 0.32 | $1B | $179M | $823M | Nov 3 |
| Q2 2024 · Jun 30 | $4.1B | — | 69.2% | $520M | $322M | — | 0.22 | $813M | $155M | $658M | Aug 1 |
| Q1 2024 · Mar 31 | $3.9B | — | 68.7% | $675M | $493M | — | 0.33 | $164M | $179M | −$15M | May 1 |
| Q4 2023 · Dec 31derived | $3.7B | — | 69.2% | $584M | $504M | — | 0.34 | $957M | $267M | $690M | Feb 17 |
| Q3 2023 · Sep 30 | $3.5B | — | 68.8% | $693M | $504M | — | 0.34 | $698M | $190M | $508M | Nov 1 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $20.1B | 69.0% | $3.6B | $2.9B | 14.4% | 1.94 | $4.5B | $876M | $3.7B | — | — |
| FY2024 · to Dec 31 | $16.7B | 68.6% | $2.6B | $1.8B | 11.0% | 1.25 | $3.4B | $790M | $2.6B | — | $0 |
| FY2023 · to Dec 31 | $14.2B | 69.5% | $2.3B | $1.6B | 11.2% | 1.07 | $2.5B | $711M | $1.8B | — | $28M |
| FY2022 · to Dec 31 | $12.7B | 68.8% | $1.6B | $698M | 5.5% | 0.45 | $1.5B | $588M | $938M | $0 | $55M |
| FY2021 · to Dec 31 | $11.9B | 68.8% | $1.2B | $1B | 8.8% | 0.69 | $1.9B | $554M | $1.3B | $0 | $55M |
| FY2020 · to Dec 31 | $9.9B | 65.0% | −$80M | −$82M | -0.8% | -0.08 | $1.5B | $376M | $1.1B | $535M | $28M |
Every number comes from BOSTON SCIENTIFIC CORP's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.